File:State of Medicon Valley 2016 beacons 20161107 (30734516631).jpg

THE BEACONS OF MEDICON VALLEY Pharmaceutical and biotechnology companies in Greater Copenhagen are a regional success story characterised by a few large companies in pharmaceuticals that are complemented by successful biotechnology companies. But Medicon Valley is more than pharmaceuticals and biotechnology. The region also has successful medical technology companies, growing science parks and the two large materials research facilities Max IV and European Spallation Source, the latter of which is currently under construction in Lund, and ESS data management centre DMSC in Copenhagen.

    In this overview, we have chosen important players from six leading areas in Medicon Valley that demonstrate the cluster’s broad scope, in business as in research.

The companies of Medicon Valley are successful, with the four large groups Novo Nordisk, H. Lundbeck, Ferring and LEO Pharma at the forefront. New biotechnology companies are cropping up the Skåne Region, for example in the relatively new science park Medicon Village, and there is a new beacon being raised in the region: with the materials research facilities Max IV and European Spallation Source, ESS.

Industrial foundations have contributed to the stable development of Medicon Valley’s four largest pharmaceutical groups: Novo Nordisk, H. Lundbeck, Ferring and LEO Pharma, all of which are located in and around Copenhagen.

The large pharmaceutical companies have nurtured many researchers and company leaders, which has also benefitted many of the new biotechnology companies that have emerged since the end of the 1990s.

The foundations have also contributed risk capital for new companies and resources for new research, generating a good circular flow in the region.

Increased pressure on prices and the phasing in of a new generation of technology with biological medicines has led to large companies being forced to make cutbacks as well as new investments. As a result, the situation in Medicon Valley can be difficult to interpret.

Six large science parks bring know-how and new companies close together. Three of them are located in and around Copenhagen, one is in Malmö and two are in Lund. The result is a new kind of ”multicellular” big business.

The equilibrium between Medicon Valley’s Zealand and Skåne Regions will be more even with the new beacon being constructed in Lund: the two materials research facilities Max IV and European Spallation Source with data centre in Copenhagen. Life science will be a crucial area. Lund is growing into an even more significant city for research.

State of Medicon Valley 2016 An Analysis of Life Science in Greater Copenhagen Commissioned and published by: Medicon Valley Alliance. This analysis has been prepared by Øresundsinstituttet and was written by Britt Andresen, Johan Wessman, Jenny Andersson, Anna Palmehag and Thea Wiborg. Layout: Jenny Andersson. November 2016

Link to the full report <a href="http://www.oresundsinstituttet.org/state-of-medicon-valley-2016-ny-analys-fran-oresundsinstituttet/" rel="nofollow">www.oresundsinstituttet.org/state-of-medicon-valley-2016-...</a>

Medicine Valley Alliance <a href="http://www.mva.org" rel="nofollow">www.mva.org</a>

Øresundsinstituttet <a href="http://www.oresundsinstituttet.org" rel="nofollow">www.oresundsinstituttet.org</a>

Copyright: Øresundsinstituttet, (CC BY 3.0)